[1]
M. Ocak, O. Soyer, B. Buyuktiryaki, B. Sekerel, and U. Sahiner, “Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety”, Allergol Immunopathol, vol. 48, no. 4, pp. 368–373, Jul. 2020, Accessed: Apr. 23, 2026. [Online]. Available: https://all-imm.com/index.php/aei/article/view/176